Evidence map›Paper›PMID 27240412›Full record

ArticleAntibiotics (Basel, Switzerland)2016

Ribosome Assembly as Antimicrobial Target.

Rainer Nikolay, Sabine Schmidt, Renate Schlömer, Elke Deuerling, Knud H Nierhaus

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Frontiers in microbiology · 2020
    Review
  7. Article
  8. Review
  9. Autophagy Induction by a Small Molecule InhibitsAntimicrobial agents and chemotherapy · 2019
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Rainer NikolayInstitut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. rainer.nikolay@charite.de.
Sabine SchmidtMolecular Microbiology, University of Konstanz, Konstanz 78457, Germany. Sabine.Schmidt@uni-konstanz.de.
Renate SchlömerMolecular Microbiology, University of Konstanz, Konstanz 78457, Germany. Renate.Schloemer@uni-konstanz.de.
Elke DeuerlingMolecular Microbiology, University of Konstanz, Konstanz 78457, Germany. elke.deuerling@uni-konstanz.de.
Knud H NierhausInstitut für Medizinische Physik und Biophysik, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany. nierhaus@molgen.mpg.de.
University of Konstanz · DECharité - Universitätsmedizin Berlin · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many antibiotics target the ribosome and interfere with its translation cycle. Since translation is the source of all cellular proteins including ribosomal proteins, protein synthesis and ribosome assembly are interdependent. As a consequence, the activity of translation inhibitors might indirectly cause defective ribosome assembly. Due to the difficulty in distinguishing between direct and indirect effects, and because assembly is probably a target in its own right, concepts are needed to identify small molecules that directly inhibit ribosome assembly. Here, we summarize the basic facts of ribosome targeting antibiotics. Furthermore, we present an in vivo screening strategy that focuses on ribosome assembly by a direct fluorescence based read-out that aims to identify and characterize small molecules acting as primary assembly inhibitors.

Indexed as

concepts for identifying assembly inhibitorsinhibitors of ribosome assemblyprotein synthesis as preferential target of antibioticsribosome as antibiotic target

Identifiers

PMID27240412
PMCPMC4929433
OpenAlexW2408297980

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.